Close Ventures is pleased to announce that it has invested a further £1.5 million in Xceleron Limited (the Company), the leading provider of innovative early-stage drug development and assessment services to the biotechnology and pharmaceutical industries. Close led a £2 million funding round, with the balance provided by Foursome Investments, as well as directors and management. This additional investment brings the total investment in Xceleron to over £4M, and will fund the Company’s expansion in its core UK and US markets.
